Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use METOCLOPRAMIDE hydrochloride safely and effectively. See full prescribing information for METOCLOPRAMIDE hydrochloride. METOCLOPRAMIDE orally disintegrating tablets. Initial U.S. Approval: 1976
Medication labelWhy this: Advisory · dailymed-prescription
Metoclopramide Orally Disintegrating Tablets is indicated in adults for the: Treatment for 4 to 12 weeks of symptomatic, documented gastroesophageal reflux disease (GERD) who fail to respond to conventional therapy. Relief of symptoms associated with acute and recurrent diabetic gastroparesis (gastric stasis). Limitations of Use: Metoclopramide Orally Disintegrating Tablets is not recommended for use in pediatric patients due to the risk of developing tardive dyskinesia (TD) and other extrapyramidal symptoms and the risk of methemoglobinemia in neonates [see Use in Specific Populations ( 8.4)]
- generic_name
- metoclopramide hydrochloride
- product_names
- Metoclopramide Hydrochloride
- ndc
- 43386-580, 43386-581, 43386-580-31, 43386-581-31
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en